The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.
Regulators said Monday they have received more than 30 reports of liver damage in patients taking alli and Xenical, the prescription version of the drug. The reports, submitted between 1999 and October 2008, included 27 hospitalized patients, and six who suffered liver failure.
FDA probes weight-loss pill alli over liver damage reports
One of the monkeys that escaped after a truck overturned on a Mississippi roadway on 28...
A civil jury in Maine has awarded $25m to a woman whose teenage daughter died from...
There is not enough evidence to confirm that Tylenol causes autism but the pain medication should...
